Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin -: Reply

被引：0
|
作者：
Griffiths, PD [1 ]
机构：
[1] UCL Royal Free & Univ Coll Med Sch, Dept Virol, London NW3 2PF, England
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 03期
关键词：
D O I：
10.1093/jac/dkf149
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prevalence of macrolide and tetracycline resistance mechanisms in Streptococcus pyogenes isolates and in vitro susceptibility to telithromycin
    Betriu, C
    Culebras, E
    Redondo, M
    Rodríguez-Avial, I
    Gómez, M
    Boloix, A
    Picazo, JJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2002, 50 (03) : 436 - U11
  • [2] Streptococcus pyogenes isolates with characterized macrolide resistance mechanisms in Spain:: in vitro activities of telithromycin and cethromycin
    Morosini, MI
    Cantón, R
    Loza, E
    del Campo, R
    Almaraz, F
    Baquero, F
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 52 (01) : 50 - 55
  • [3] Molecular Mechanisms of Tetracycline and Macrolide Resistance and emm Characterization of Streptococcus pyogenes Isolates in Tunisia
    Hraoui, Manel
    Boutiba-Ben Boubaker, Ilhem
    Doloy, Alexandra
    Ben Redjeb, Saida
    Bouvet, Anne
    [J]. MICROBIAL DRUG RESISTANCE, 2011, 17 (03) : 377 - 382
  • [4] In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms
    Morosini, MI
    Cantón, R
    Loza, E
    Negri, MC
    Galán, JC
    Almaraz, F
    Baquero, F
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) : 2427 - 2431
  • [5] Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile
    Palavecino, EL
    Riedel, I
    Berrios, X
    Bajaksouzian, S
    Johnson, D
    Kaplan, E
    Jacobs, MR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) : 339 - 341
  • [6] Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Ankara, Turkey
    Colakoglu, Sule
    Alacam, Ruhi
    Hascelik, Gulsen
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (6-7) : 456 - 459
  • [7] Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel
    Nir-Paz, Ran
    Block, Colin
    Shasha, David
    Korenman, Zinaida
    Gorodnitzky, Zeev
    Jaffe, Joseph
    Ron, Merav
    Michael-Gayego, Ayelet
    Cohen-Poradosu, Ronit
    Shapiro, Mervyn
    Moses, Allon E.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (04) : 313 - 319
  • [8] In vitro activities of tigecycline against erythromycin-resistant Streptococcus pyogenes and Streptococcus agalactiae:: Mechanisms of macrolide and tetracycline resistance
    Betriu, C
    Culebras, E
    Rodríguez-Avial, I
    Gómez, M
    Sánchez, BA
    Picazo, JJ
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (01) : 323 - 325
  • [9] Streptococcus pyogenes isolates with high-level macrolide resistance and reduced susceptibility to telithromycin associated with 23S rRNA mutations
    Farrell, DJ
    Shackcloth, J
    Barbadora, KA
    Green, MD
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 817 - 818
  • [10] In vitro activity of telithromycin (HMR 3647) against Greek Streptococcus pyogenes and Streptococcus pneumoniae clinical isolates with different macrolide susceptibilities
    Ioannidou, S
    Tassios, PT
    Zachariadou, L
    Salem, Z
    Kanelopoulou, M
    Kanavaki, S
    Chronopoulou, G
    Petropoulou, N
    Foustoukou, M
    Pangalis, A
    Trikka-Graphakos, E
    Papafraggas, E
    Vatopoulos, AC
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2003, 9 (07) : 704 - 707
12345